Labor induction at 37.0 to 37.6 weeks of gestation
ProcedureDiagnosis of FGR with induction at 37 weeks 0 days of gestation to 37 weeks and 6 days
NCT Number: NCT03046355
The goal of the study is to determine whether labor induction at 37 weeks of pregnancy can improve the baby's health at birth when compared with delivery at a later point in the pregnancy.
Looking for future studies?
Notify Me18 year–39 year
Female
Interventional
Not applicable
Bellaire - Memorial Hermann, Houston, Texas, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diagnosis of FGR with induction at 37 weeks 0 days of gestation to 37 weeks and 6 days
Diagnosis of FGR managed with expectant monitoring and delivery as indicated
Time frame: Immediately at birth
NICHD is National Institute of Child Health and Human Development The NICHD nomogram will indicate their birth weight percentile based on their gestational age and ethnicity
Time frame: Up to 6 weeks after delivery
Composite neo-natal morbidity (CNM) is any of the following: Apgar score <5 at 5 minutes, seizure, sepsis, hypoglycemia requiring intravenous treatment, mechanical ventilation, CPAP (continuous positive airway pressure) or high-flow nasal cannula for >2 hours, oxygen supplementation with FiO2 (fraction of inspired oxygen) >30% for >4 hours, death before discharge or IUFD (intrauterine fetal death).
Time frame: Up to 6 weeks after delivery
Composite maternal morbidity (CMM) is any of the following: chorioamnionitis, transfusion of blood products, endometritis, wound infection or separation, deep venous thrombosis, pulmonary embolism, admission to the intensive care unit, or death. Rates of cesarean section as well as indications in each group will also be evaluated.
Time frame: Immediately at birth
Time frame: Up to 6 weeks after delivery
NICU is neo-natal intensive care unit
Time frame: Immediately at birth
SGA is small for gestational age when birthweight <10% for gestational age
The University of Texas Health Science Center, Houston
Other
Timing of Delivery in Fetal Growth Restriction of Uncomplicated Women: A Randomized Controlled Trial (GROW Trial)
Acronym: GROW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04311749
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
San Francisco, California, United States
View Trial DetailsNCT05814198
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05059093
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Casablanca, Morocco
View Trial DetailsNCT03067298
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Québec, Canada
View Trial Details